Marco Orsini Federici

Author

Also Known As

Evangelia Mourvaki, Federici, Marco, M Federici, M Orsini Federici, M. Federici, M. Orsini Federici, MARCO O. ORSINI FEDERICI, Marco Federici, Marco O. Federici, Marco Orsini Federici

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

University of Perugia Eli Lilly (Italy)Eli Lilly (United States)Eli Lilly (Germany)Addenbrooke's Hospital

About

Marco Orsini Federici is an author at University of Perugia specializing in diabetes, engineering, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	3	3	242
2	Medicine	2	2	191
3	Health Sciences	1	1	40
4	Natural Sciences	1	1	76
5	Biochemistry	1	1	40

Marco Orsini Federici

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes Roman Hovorka, Valentina Canonico, Ludovic J. Chassin, Physiological Measurement	2004	1.2K
Closing the Loop: The Adicol Experience Roman Hovorka, Ludovic J. Chassin, Malgorzata E. Wilinska, Diabetes Technology & Therapeutics Diabetes ManagementPerformance StudiesEngineeringHuman-in-the-loopAdicol Experience	2004	151
Control oriented model of insulin and glucose dynamics in type 1 diabetics P.G. Fabietti, Valentina Canonico, Marco Orsini Federici, Medical & Biological Engineering & Computing Type 1Diabetes ManagementGlucose DynamicsDiabetesInsulin Management	2006	83
Two for One: Diffusion Models and Force Fields for Coarse-Grained Molecular Dynamics Marloes Arts, Victor García Satorras, Chin‐Wei Huang, Journal of Chemical Theory and Computation Biophysical ModelingCg Force FieldEngineeringMolecular BiologyComputational Chemistry	2023	76
A model of the endogenous glucose balance incorporating the characteristics of glucose transporters Tom Arleth, Steen Andreassen, Marco Orsini Federici, Computer Methods and Programs in Biomedicine Energy MetabolismBiochemistryBioenergeticsGlucose TransportersPhysiology	2000	40
Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study Marco Orsini Federici, Janette P. McQuillan, Giovanni Biricolti, Diabetes Therapy	2018	37
Privacy impact assessment in the design of transnational public health information systems: the BIRO project Concetta Tania Di Iorio, Fabrizio Carinci, Joseph Azzopardi, Journal of Medical Ethics	2009	29
Patient preferences and health state utilities associated with dulaglutide and semaglutide injection devices among patients with type 2 diabetes in Italy Kristina S. Boye, Louis S. Matza, Katie D. Stewart, Journal of Medical Economics	2019	21
Group of Signs: A New Method to Evaluate Glycemic Variability Francesco Zaccardi, Paola Di Stefano, E. Busetto, Journal of Diabetes Science and Technology	2008	20
Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes Louis S. Matza, Kristina S. Boye, Jessica Jordan, Patient Preference and Adherence	2018	17

Page 1